HB352: HB352 Georgia Gestational Diabetes Management Act; enact
Last action May 14, 2025 · Effective Date 2025-07-01
House Bill 352 expands Georgia Medicaid's coverage of continuous glucose monitors to include recipients with gestational diabetes, updating the state's coverage rules starting July 1, 2025.
In plain language
Georgia Medicaid already covers continuous glucose monitors for some people with diabetes, based on criteria written into state law (O.C.G.A. § 49-4-159.4). Those criteria required that a recipient either use daily insulin or have a history of serious low blood sugar episodes. This bill, titled the Georgia Gestational Diabetes Management Act, adds a third path to qualify: having gestational diabetes, a form of diabetes that develops during pregnancy. The bill keeps the existing requirements that a treating practitioner diagnose the recipient with diabetes and confirm the recipient or their caregiver has been trained to use the monitor. It also moves the effective date for this Medicaid coverage benefit from July 1, 2023 to July 1, 2025. Once in effect, the Georgia Department of Community Health must offer this coverage through the most cost-effective delivery method available.
What the bill does
- Adds gestational diabetes as a qualifying condition for Georgia Medicaid coverage of continuous glucose monitors, alongside existing criteria for insulin users and people with severe hypoglycemia.
- Updates the effective date of this Medicaid benefit requirement from July 1, 2023 to July 1, 2025.
- Keeps in place the existing requirement that a treating practitioner diagnose the recipient with diabetes mellitus before coverage applies.
- Keeps the requirement that the recipient or their caregiver show they have been trained to use the monitor, evidenced by a prescription.
- Directs the department to deliver this Medicaid benefit through the most cost-effective channel available.
- Gives the Act a short title, the 'Georgia Gestational Diabetes Management Act.'
Who it affects
Pregnant Georgians on Medicaid who are diagnosed with gestational diabetes, their treating practitioners who must document diagnosis and training, and the Georgia Department of Community Health, which administers Medicaid and must update its coverage criteria and delivery methods accordingly.
Why it matters
Continuous glucose monitors let people track blood sugar without frequent finger-prick tests, which can help manage gestational diabetes during pregnancy. By adding this condition as a qualifying category, more Medicaid recipients would become eligible for monitor coverage without needing to also meet the insulin-use or severe hypoglycemia criteria.
Key provisions
- Section 1 names the short title, the 'Georgia Gestational Diabetes Management Act.'
- Section 2 amends O.C.G.A. § 49-4-159.4(a) to change the coverage start reference from July 1, 2023 to July 1, 2025.
- Section 2 adds 'Has gestational diabetes' as a new standalone qualifying criterion under paragraph (3), separate from insulin use or hypoglycemia history.
- Section 2 retains the diagnosis and training documentation requirements in paragraphs (1) and (2).
- Section 3 repeals any conflicting laws.
From the bill
“Has gestational diabetes”
Status timeline
- Effective Date 2025-07-01
- Act 260
- House Date Signed by Governor (House)
- House Sent to Governor (House)
- House Agreed Senate Amend or Sub (House)
- Senate Passed/Adopted By Substitute (Senate)
- Senate Third Read (Senate)
- Senate Taken from Table (Senate)
Show full history (18 actions)
- Senate Tabled (Senate)
- Senate Read Second Time (Senate)
- Senate Committee Favorably Reported By Substitute (Senate)
- Senate Read and Referred (Senate)
- House Passed/Adopted By Substitute (House)
- House Third Readers (House)
- House Committee Favorably Reported By Substitute (House)
- House Second Readers (House)
- House First Readers (House)
- House Hopper (House)
Sponsors
- Devan Seabaugh (R, HD-034)
- Sharon Cooper (R, HD-045)
- Danny Mathis (R, HD-133)
- Darlene Taylor (R, HD-173)
- Teddy Reese (D, HD-140)
- Carter Barrett (R, HD-024)
- Kay Kirkpatrick (R, SD-032)
Votes
- House voteFebruary 24, 2025
169 yea, 2 nay (2 not voting, 7 absent)
- House voteApril 4, 2025
163 yea, 2 nay (3 not voting, 12 absent)
- Senate voteApril 4, 2025
51 yea, 1 nay (1 not voting, 3 absent)
Topics
- Medicaid coverage
- gestational diabetes
- continuous glucose monitors
- maternal health
- diabetes management